PPD Clinical Trial Forecasting Suite

PPD's Clinical Trial Forecasting Suite uses AI and machine learning to predict milestones, streamline site selection, forecast patient enrollment, and anticipate delays. The tool is continuously refined with real-time data from over 400 studies, helping customers achieve an average time savings of 12 weeks compared to traditional methods.

AI named PPD Clinical Trial Forecasting Suite from February 2026 to March 2026.